Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Item
http://www.wikidata.org/entity/Q38980046
A surprising treatment response in a patient with rare isolated growth hormone deficiency, type IB.Alcohol and Stress Activation of Microglia and Neurons: Brain Regional Effects.The role of the orbitofrontal cortex in alcohol use, abuse, and dependence.Genetic variations in genes of the stress response pathway are associated with prolonged abstinence from heroin.Differential effects of acute versus chronic stress on ethanol sensitivity: evidence for interactions on both behavioral and neuroimmune outcomes.Plasma corticosterone, epinephrine, and norepinephrine levels increase during administration of nitrous oxide in rats.Role of TLR4 in the Modulation of Central Amygdala GABA Transmission by CRF Following Restraint Stress.Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.Involvement of activated brain stress responsive systems in excessive and "relapse" alcohol drinking in rodent models: implications for therapeutics.Stress and Obesity: Are There More Susceptible Individuals?
P2860

Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Item
http://www.wikidata.org/entity/Q38980046
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Alcohol, stress, and glucocort ...... apse in alcohol use disorders.
@en
type
label
Alcohol, stress, and glucocort ...... apse in alcohol use disorders.
@en
prefLabel
Alcohol, stress, and glucocort ...... apse in alcohol use disorders.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P698
P921
P932
P356
P1433
P1476
Alcohol, stress, and glucocort ...... apse in alcohol use disorders.
@en
P2093
P2860
P304
P31
P356
10.1016/J.NEUROPHARM.2017.01.037
P478
P577
P698
P921
P932